AU3134500A - Plants and feed baits for controlling damage from feeding insects - Google Patents

Description

WO 00/53000 PCT/AU00/00181 PLANTS AND FEED BAITS FOR CONTROLLING DAMAGE FROM FEEDING INSECTS Field of the Invention: 5 The present invention relates to the problem of damage caused to plants (e.g. crop plants) from feeding insects such as lepidopterans and coleopterans. More particularly, the present invention relates to a plant capable of expressing, in a tissue or tissues susceptible to damage by feeding insects, an exogenous protein(s) which may reduce damage to the plant by 10 inhibiting feeding, growth and/or development of insects. Background of the Invention: Entomiopoxviruses (EPVs) are insect-specific members of the family Poxviridae (Murphy et al., 1995) that collectively infect hosts such as 15 caterpillars, beetles and locusts (Arif, 1995). Like other members of the poxvirus family (i.e., the chordopoxviruses; ChPVs), EPVs have large double stranded DNA genomes, produce complex virions, and replicate in the cytoplasm of infected cells (Moss, 1996). While these and other molecular characteristics confirm their poxvirus affinities (Osborne et al., 1996), other 20 notable traits differentiate EPVs from ChPVs, and ally them instead with unrelated groups of insect-infecting viruses. Foremost among these traits is production of the distinctive proteinaceous structures known as spheroids and spindle bodies. Spheroids develop in the cytoplasm of EPV-infected cells at the site of 25 viral mnorphogenesis, and when mature, occlude large numbers of infectious virions (Goodwin et al., 1991). They are the agent of horizontal transmission of EPVs, and while their major constituent matrix protein (spheroidin; Hall & Moyer, 1991) has no known homologue outside the taxon, the bodies themselves are assumed to protect virions from detrimental environmental 30 factors such as desiccation and exposure to u.v. light. In this respect they are functionally analogous to the polyhedral bodies which occlude virions of members of the baculovirus family and the cytoplasmic polyhedrosis group of reoviruses. Most EPVs also encode and produce a protein known as fusolin, which 35 has been shown to be the major constituent of structures known as spindle WO 00/53000 PCT/AU00/00181 2 bodies (SBs; Dall et al., 1993); these structures have been described from many, but not all, members of EPV genera A and B that infect caterpillars and beetle larvae (Goodwin et al., 1991). In the Heliothis armigera EPV (HaEPV)(Fernon et al., 1995), the fusolin protein has a calculated M, of 5 40132, and the mature form of the protein has an apparent size of 50K when analysed by SDS-PAGE (Dall et al., 1993). The protein has been found to accumulate in vesicular structures derived from cellular endoplasmic reticulum, where it eventually aggregates and crystallises into SBs (Lai-Fook and Dall, in press). Although other proteins are known to be co-located in 10 SBs (e.g., the ER-specific chaperone protein, BiP; Lai-Fook and Dall, in press), analysis of purified SB preparations shows that fusolin, in its monomeric and multimeric forms (Dall et al., 1993), is by far the most abundant constituent. Genes encoding.homologues of the fusolin protein, in this context known variously as "gp37", "37K protein", "SLP" (spindle-like protein), etc., 15 have also been described from a number of nuclear polyhedrosis (NPV) baculoviruses, including the Autographa californica, Bombyx mori, Choristoneura fumiferana, Lymantria dispar, Orgyia pseudotsugata NPVs and Xestia c-nigrum GV (AcMNPV, BmMNPV, CfMNPV, LdMNPV, OpMNPV and XcGV, respectively; Ayres et al., 1994; Gomi et al., 1999; Liu and Carstens, 20 1996; Kuzio et al., 1999; Ahrens et al., 1997; Hayakawa et al., 1999). In some of these (e.g., OpNPV; Gross et al., 1993), the protein has been observed within spindle-like bodies (SLBs) in the cytoplasm of infected cells. SLBs have also been observed in the cytoplasm of cells infected with other NPVs (e.g., from Cadra cautella NPV, Adams and Wilcox 1968; see also Adams and 25 McClintock, 1991; Cunningham, 1971; Huger and Kreig, 1968; Smirnoff, 1970). All members of the fusolin group of proteins, irrespective of their viral family of origin, are united by an absolute conservation of amino acid residues at a number of positions in their sequences, in particular in the N 30 terminal and central regions of the molecule. These conserved residues include HGX (standard one letter amino acid code, where X is an aromatic amino acid) and ARQ motifs near the N-terminal of the deduced protein sequence (Table 1), and e.g. a VRWQR (SEQ ID NO:1) sequence elsewhere within the deduced amino acid sequence (Figure 1). This conservation of 35 sequence elements, like that of the protein's intracellular location, as previously described, suggests that all members of the group also share a WO 00/53000 PCT/AU00/00181 3 common role in the cycle of virus infection and replication, perhaps in influencing the relationship of the viruses with their hosts (Sriskantha et al., 1997). Nevertheless, the function(s) of members of this group of proteins, and the SB/SLB structures that they form, remain a topic of on-going 5 investigation. Studies by Xu and Hukuhara (1992, 1994) suggested that a factor associated with preparations of Pseudaletia separata EPV (PsEPV), and subsequently identified as fusolin (Hayakawa et al., 1996), was capable of enhancing the infectivity of a heterologous nuclear polyhedrosis virus (P. 10 unipunctata NPV). Further studies have shown that a similar effect can be seen in transgenic rice plants in which this protein has been expressed (Hukuhara et al., 1999). Similarly, the SBs of the cupreous chafer (Anomala cuprea) have been shown to be capable of acting in the same manner (Mitsuhashi et al., 1998). The role(s) of fusolin protein in the context of 15 homologous EPV systems has not, however, been previously subjected to detailed investigation. Through experiments involving bioassays using SBs of Heliothis armigera EPV (HaEPV) and Dermolepida albohirtum EPV (DaEPVSR), the present applicants have determined, unexpectedly, that consumption of 20 spindle bodies alone can effect feeding, growth and development of insect larvae. Further, through experiments conducted using recombinant EPVs wherein the fusolin gene has been replaced with a P-galactosidase marker (i.e., to render the recombinant EPVs fusolin negative [fus -]), the present applicants have also been able to provide evidence to show that it is the 25 fusolin protein component of SBs that is responsible for these effects. Moreover, the latter experiments have indicated that fusolin enhances the infectivity of the homologous EPV virus. As a result, it has been realised that SBs, SLBs and constituent proteins of these structures may be advantageously used in strategies designed to reduce damage caused to 30 plants by feeding insects. Summary of the Invention: In a first aspect, the present invention provides a plant transformed with at least one polynucleotide molecule comprising a nucleotide 35 sequence(s) encoding one or more constituent protein(s) of spindle bodies or spindle-like bodies from an insect virus, operably linked to a suitable WO 00/53000 PCT/AU00/00181 4 promoter sequence(s), wherein said transformed plant expresses said protein(s) in, at least, plant tissue or tissues susceptible to damage by feeding insects. In a second aspect, the present invention provides a feed bait 5 composition comprising spindle bodies or spindle-like bodies from an insect virus, or one or more constituent protein(s) of said spindle bodies or spindle like bodies, together with an agriculturally acceptable carrier. Detailed disclosure of the Invention: 10 As mentioned above, the invention provides a plant capable of expressing one or more constituent SB/SLB protein(s) in tissues (e.g. leaf tissue or a product tissue such as fruit tissue) susceptible to damage by feeding insects. Thus, when feeding insects feed on a plant according to the invention, they will ingest, along with plant tissue, the expressed constituent 15 SB/SLB protein(s). Since SBs/SLBs appear to inhibit feeding, growth and/or development of insects and, potentially, increase susceptibility to infection from insect pathogens (and thereby insect death), ingestion of one or more of the constituent SB/SLB protein(s) by feeding insects may reduce further damage to the plant. In addition, it is believed that inhibiting the feeding, 20 growth and/or development of insects also increases the likelihood of insect death resulting from, for example, adverse environmental conditions, predators and chemical and other biological agents (e.g. pathogenic bacteria). The plant according to the invention may be any plant of agricultural, arboricultural, horticultural or ornamental value that is susceptible to 25 damage by feeding insects. Preferably, the plant is selected from plants of agricultural value such as cereals (e.g. wheat and barley), vegetable plants (e.g. tomato and potato) and fruit trees (e.g. citrus trees and apples). Other preferred plants include tobacco and cotton. The polynucleotide molecule(s) comprising a nucleotide sequence 30 encoding one or more constituent SB/SLB protein(s) operably linked to a suitable promoter sequence(s), may be any polynucleotide molecule(s) that may be stably segregated and retained in daughter cells. Preferably, the polynucleotide molecule(s) is stably integrated into a non-essential site within the plant genome (as may be achieved by the well known technique of 35 homologous recombination).

WO 00/53000 PCT/AU00/00181 5 Preferred constituent SB/SLB proteins are fusolins, fusolin-like proteins and the ER-specific chaperone BiP proteins and homologues thereof. Preferred fusolin proteins include those from HaEPV, Pseudaletia separiata EPV (PsEPV), Choristoneura biennis EPV (CbEPV) and Dermolepida 5 albohlirtum EPV (Stone River isolate; DaEPVSR; Dall et a], unpublished). Most preferred is the fusolin from HaEPV such as is described in the present applicant's Australian Patent No. 668734, the disclosure of which is to be regarded as incorporated herein by reference. The term "fusolin-like protein" refers to all insect virus proteins and 10 functional fragments thereof which are capable of inhibiting feeding, growth and/or development in at least one insect species, and which preferably also increases susceptibility in at least one insect species to infection from at least one pathogen virus (e.g. a virus). As such, the term includes all proteins (and functional fragments thereof) from entomopoxviruses (EPVs), nuclear 15 polyhedrosis (NPV) and granulosis (GV) baculoviruses, and all other insect viruses, that demonstrate > 35% amino acid sequence identity (as calculated by the GCG Gap algorithm; Devereux et al., 1984) to the HaEPV fusolin protein and which include the following partial amino acid sequences: HGX (standard one letter amino acid code, where X is an aromatic residue), and 20 ARQ motifs near the N-terminal, and VRWQR (SEQ ID NO:1) elsewhere. Preferred fusolin-like proteins include those from AcMNPV, BmMNPV, CfMNPV, LdMNPV, OpMNPV and XcGV. Where the plant expresses more than one constituent SB/SLB protein, the plant may be transformed with a single polynucleotide molecule such 25 that the proteins are expressed from single or multicistronic messenger RNA. Alternatively, the proteins might be expressed from two or more polynucleotide molecules co-transformed into the plant. Where the plant expresses all of the constituent SB/SLB protein(s) of an insect virus, the protein(s) may be present in the plant tissues in the form 30 of SB/SLB structures. Suitable promoter sequence(s) for the expression of the nucleotide sequence(s) encoding the constituent SB/SLB protein(s), may be selected from any promoter sequence which is functional in plants. Preferred promoter sequences include those from plants, plant viruses and plant 35 viroids. Particularly preferred promoter sequences include the cauliflower WO 00/53000 PCT/AU00/00181 6 mosaic virus (CaMV 35S) promoter element, and promoter elements from the sub-clover stunt virus (SCSV). Plants according to the present invention may also express an exogenous toxin or other exogenous agent that is deleterious to insects. For 5 example, the plant may also express a Bacillus thuringiensis 6-toxin, an insect neurohormone, or an antisense RNA or ribozyme targeted against an essential cellular function. The heterologous toxin or deleterious agent may be encoded by a nucleotide sequence (operably linked to a suitable promoter sequence) borne on the polynucleotide molecule(s) encoding the one or more 10 constituent SB/SLB protein(s) or may be borne on a further polynucleotide molecule which has been co-transformed into the plant. Transformation of the plant with the polynucleotide molecule(s) may be achieved by any of the methods well known in the art including Agrobacterium transformation and electroporation. 15 As will be appreciated, the benefits achieved by expressing one or more constituent SB/SLB protein(s) in plants might also be achieved by producing feed baits comprising spindle bodies or spindle-like bodies from an insect virus, or one or more constituent protein(s) of said spindle bodies or spindle-like bodies. Thus, feed bait compositions according to the present 20 invention comprise spindle bodies or spindle-like bodies from an insect virus, or one or more constituent protein(s) of said spindle bodies or spindle like bodies, together with an agriculturally acceptable carrier. The feed bait compositions may be in a liquid or gel form, but more preferably are in a solid form. The spindle bodies, spindle-like bodies or 25 constituent SB/SLB protein(s) may comprise 0.05 to 15.0% (by weight) of the composition. In addition to the spindle bodies, spindle-like bodies or constituent SB/SLB protein(s) and the agriculturally acceptable carrier, the feed bait composition may further comprise a pheromone(s) or other chemical attractant to insects. For liquid formulations the agriculturally 30 acceptable carrier may be selected from ingredients such as milled clays or edible carrier substances such as plant materials, molasses or raw sugar, and microorganisms such as yeasts or other fungi, algae or bacteria. For solid feed bait compositions, the agriculturally acceptable carrier may be selected from ground or fragmented plant material and other materials as described 35 above processed to an appropriate form. The solid feed bait compositions may be provided as pellets and applied by casting over an area containing a WO 00/53000 PCT/AU00/00181 7 plant for which protection against damage by feeding insects is desired. Liquid or gelled feed bait compositions may be applied to a plant by spraying. The spindle bodies, spindle-like bodies or constituent SB/SLB 5 protein(s) included in the feed bait composition may be isolated from natural sources or, more conveniently, produced recombinantly in, for example, bacteria, yeast, insect or mammalian cell cultures. Insects having ingested spindle bodies, spindle-like bodies or constituent SB/SLB protein(s) as the result of having fed on a plant or feed 10 bait composition according to the present invention may, as mentioned above, be expected to cause reduced damage to plants either as a result of reduced feeding/growth and/or to have reduced life times as a result of an increased susceptibility to adverse environmental conditions or chemical and biological agents. Accordingly, the present invention further extends to 15 methods where a plant in accordance with the first aspect or a plant to which a feed bait composition in accordance with the second aspect has been applied, is treated with an insecticidal chemical and/or biological agent, and especially one whose activity has been shown to be higher against smaller, as compared to larger, insect larvae. Suitable chemical agents include 20 organophosphate compounds and suitable biological agents include pathogenic bacteria and insect viruses (especially Bacillus thlzuringiensis [Bt] and nuclear polyhedrosis baculoviruses). These agents may be applied by any of the methods well known in the art and, most conveniently, by spraying. Preferably, the chemical or biological agent is applied in the form 25 of a composition comprising an agriculturally acceptable carrier. Where used with a feed bait composition, it is to be understood that the feed bait composition might also be applied to the plant before, after or concurrently with the chemical and/or biological agent. The terms "comprise", "comprises" and "comprising" as used 30 throughout the specification are intended to refer to the inclusion of a stated component, feature or step or group of components, features or steps with or without the inclusion of a further component, feature or step or group of components, features or steps. The invention is hereinafter described with reference to the 35 accompanying figures and the following, non-limiting examples.

WO 00/53000 PCT/AU00/00181 8 Brief Description of the accompanying figures: Figure 1: Provides a comparison of a partial amino acid sequence of the fusolin protein of Dermolepida albohirtum entomopoxvirus (Stone River 5 isolate; DaEPVsR) with corresponding regions of the same protein from other selected entompoxviruses and baculoviruses. Boxed text shows DaEPVSR fusolin sequence as determined by N-terminal amino acid analysis (bold) or conceptual translation of coding nucleotide sequence. Asterisks above the boxed DaEPVSR sequence show residues that differ from others of beetle 10 derived EPVs (MmEPV and AcEPV); those below the alignment show residues conserved across conceptual proteins from EPVs, NPVs and Gvs. (MmEPV: Melolontha minelolontha EPV; AcEPV: Anomala cuprea EPV; CbEPV: Chloristoneura biennnis EPV; HaEPV: Heliothis armigera EPV; BmNPV: Bombyx mori nuclear polyhedrosis virus [NPV]; CfNPV: Choristoneura 15 fumiferanae NPV; XcGV: Xestia c-nigrum granulosis virus). Figure 2: Provides a reproduction of a Coomassie blue stained SDS PAGE gel of fractionated spindle bodies from HaEPV and DaEPVR. Figure 3: Provides a map for the transfer vector pEPAS3. Figure 4: Shows protein constituents of wild-type and recombinant 20 [fus"] isolates of IIaEPV, visualised (a) by staining with Coomassie Blue, or (b) by Western blotting with antiserum to HaEPV fusolin. Arrows indicate positions of fusolin protein. Figure 5: Infectivity of wild-type and recombinant [fus -)] isolates of HaEPV for 48 hr old Helicoverpa armigera larvae. 25 Figure 6: Shows weight gain profiles of 48 hr old Helicoverpa armigera larvae after 7 days feeding on diet contaminated with wild-type and recombinant [fusF)] isolates of HaEPV. Figure 7: Shows the developmental fate of 48 hr old Helicoverpa arnmigera larvae after 21 days feeding on diet contaminated with wild-type 30 and recombinant [fus"] isolates of HaEPV.

WO 00/53000 PCT/AU00/00181 9 Example 1: Separation techniques for purification/isolation of HaEPV and DaEPVSR viruses and spindle bodies. 5 Preparations of spheroids and spindle bodies (SBs) of Heliothis armigera entomopoxvirus (HaEPV) and Dermolepida albohlirtum entomopoxvirus (DaEPVsa) were made from macerated cadavers of larvae of Spodoptera litura (Lep: Noctuidae) and Dermolepida albohlirtum (Col: Melolonthinae), respectively, using a process of repeated differential 10 centrifugation. These preparations were layered onto a 36% (w/w) solution of CsCl and spun overnight at 27000 rpm in a Beckman SW41 rotor. Fractions containing high numbers of spindle bodies were collected and pooled, and the process was repeated until a sufficient degree of purity was obtained. Purified preparations of SBs were washed three times in 15 phosphate-buffered saline (PBS), then stored at SoC in the same solution until use. Preparations were analysed by light microscopy (LM) and by examination of protein composition by SDS-PAGE, the latter using techniques previously described (Dall et al., 1993). These protocols showed 20 that a very high level of purity could be achieved for HaEPV (Figure 2, lane 2), and that a satisfactory degree of purity could be obtained for DaEPVSR (Figure 2, lane 4). Partial characterisation of DaEPVsy fusolin Protein constituents of preparations of DaEPVR were separated by 25 SDS-PAGE and immobilised by western blotting onto PVDF membrane (Dall et a]., 1993). A band corresponding to a protein of about 50KMr, and thus representing the putative DaEPVSR fusolin protein, was isolated, and the N terminal amino acid sequence of the immobilised protein was obtained by use of an Applied Biosystems Procise Sequencer. 30 The resultant amino acid sequence (HGYITFPIARQRR (SEQ ID NO: 2); standard one letter code) was compared with others in GenBank using the NCBI Blast algorithm (Altschul et al., 1990). This and other analyses (using the GCG Gap algorithm) showed that this sequence corresponded to those known from fusolin/gp37 proteins from baculoviruses (nuclear polyhedrosis 35 and granulosis viruses; NPVs and GVs, respectively), and other EPVs, and that it most closely matched forms of the protein previously identified from WO 00/53000 PCT/AU00/00181 10 EPV isolates from coleopteran hosts (viz., Melolontha melolontha EPV [GenBank accession X77616], with which it was identical, and Anomala cuprea EPV [AB000780]; Table 1). 5 Table 1: Alignment of the N-terminal amino acid sequence of DaEPVSR fusolin with other selected sequences. Virus Sequence Sequence GenBank Listing No. Accession Accession Dermolopida albohirtum EPV (Stone River isolate) HGYITFPIARQRR SEQ ID NO: 2 Melolonitha menlolontha EPV HGYITFPIARQRR SEQ ID NO: 2 (X77616) Anomala cuprea EPV HGYVTFPIARQRR SEQ ID NO: 3 (AB000780) Chorisloneura bionnis EPV HGYMTFPIARQRR SEQ ID NO: 4 (M34140) Heliothis armigora EPV HGYMTFPIARQRR SEQ ID NO: 4 (L08077) Pseudaletia separata EPV HGYMTFPIARQRR SEQ ID NO: 4 (BAA09138) Bonmbvx mnori NPV HGYLSLPTARQYK SEQ ID NO: 5 (U55071) Chorisloneura fumifJerana NPV HGYLSVPVARQYK SEQ ID NO: 6 (U26734) Mamneslra brassica NPV HGYLSYPVARQYK SEQ ID NO: 7 (AF108960) Xestia c-nigrum GV IIGFMLYPLARQYR SEQ ID NO: 8 (AF162221) conserved residues ** ... *. ***. Genomic DNA of DaEPVsa was prepared by dissolution of purified 10 preparations of spheroids/SBs in a high pH carbonate buffer containing 40mM thioglycollic acid. After the dissolution of spheroids/SBs was essentially complete (as assessed by LM examination), the solution was neutralised by addition of 10 mM Tris buffer, pH8.0, digested with protease K for 3hr, boiled for 10 minutes then centrifuged at 15K g for 10 minutes to 15 remove residual debris. The viral genomic DNA was collected with the supernatant and stored at -20 0 C. Viral genomic DNA was used as template in polymerase chain reaction (PCR) protocols with custom oligonucleotide primers (oligos). A segment of the DaEPVSR fusolin-encoding gene was amplified by use 20 of custom oligos NFUS1 and EPSP6. Oligo NFUS1 was designed by reverse translation of the DaEPVR N terminal amino acid sequence described above, and comprised the sequence: (NFUS1) 5'-cay ggw tat atr can ttt cct ata gc-3' (SEQ ID NO: 9), where n represents any nucleotide, r = a or g, w = a or t, and y = c or t.

WO 00/53000 PCT/AU00/00181 11 Oligo EPSP6 was designed to bind to a region known to be highly conserved in other forms of the gene, located some 700 nucleotides downstream of the translation initiation codon, and comprised the sequence: (EPSP6) 5'-aca rtt rta raa wcc ttc wcc yac-3' (SEQ ID NO: 10), 5 where n represents any nucleotide, r = a or g, w = a or t, and y = c or t. PCR amplifications using oligo pair NFUS1 and EPSP6 and DaEPVSR DNA gave rise to a product of approximately 700 bp, as assessed by agarose gel electrophoresis. This product was cloned into plasmid pGem-TEasy (Promega), in order to allow characterisation of its constituent nucleotide 10 sequence. The plasmid was replicated in Escherichia coli strain DH10p, and purified with a commercial reagent/protocol (Wizard Prep; Promega). Analysis of the amplified nucleotide sequence used universal forward and reverse oligo nucleotides, with Elmer Perkin "Big Dye" reaction mix and PCR cycle sequence methodology as recommended by that supplier. 15 Products of the sequencing reaction were analysed on an ABA377 DNA sequencer. The DNA sequence obtained was analysed using the GCG Map and Translate algorithms (Devereux et al., 1984); related sequences were obtained from GenBank using the NCBI Blast algorithm. Comparative sequence analyses used GCG Gap and PileUp algorithms 20 (Devereux et al., 1984). As shown in Table 1, the available DaEPVsI fusolin amino acid sequence shows closest relationships to analogous regions (as construed by alignment from the N-termini of the mature forms) of fusolin proteins from EPVs of coleopteran hosts (MmEPV and AcEPV), but also shows significant levels of sequence identity to other fusolin and gp37 25 proteins from EPVs and baculoviruses, respectively, from lepidopteran hosts. Alignment of conceptual amino acid sequences (Figure 1) shows that DaEPVSR fusolin has a unique sequence (as indicated by asterisks above the line, which show positions that differ with respect to other sequences of coleopteran EPV origin), but also that it retains the same groupings of 30 conserved residues found in related proteins from other EPVs and baculoviruses from coleopteran and lepidopteran origins (asterisks below the alignment). As shown in Table 2, percentage identities between selected fusolin sequences range from 38.0 to 89.7% for HaEPV (complete molecule) and 45.2 to 81.8 % for DaEPVsa (corresponding regions). 35 WO 00/53000 PCT/AU00/00181 12 Table 2: Relationships of deduced HaEPV and DaEPVSR fusolin proteins with homologues from other entomopox- and baculovirus sources. % identity % similarity 'HaEPV / PsEPV 89.7 92.9 / CbEPV 62.9 72.6 / AcEPV 55.5 71.3 / MmEPV 52.3 67.6 / MbNPV 46.3 61.2 / BmNPV 42.8 61.6 / XcGV 41.7 63.6 / CfNPV 38.0 58.8 bDaEPVsl MmEPV (19-238) 81.8 87.3 SAcEPV (17-236) 72.7 81.4 SCbEPV (21-241) 60.5 75.0 / HaEPV (21-240) 63.6 78.2 I BmNPV (20-236) 47.7 62.0 SCfNPV (20-236) 45.2 61.8 / XcGV (19-225) 47.0 66.8 Identities and GenBank accession numbers of viruses/sequences shown in Table 2 are as presented in Table 1. a Comparison of HaEPV fusolin with other viral homologues employs deduced full length protein sequences, using the GCG Gap algorithm at default gap weight and penalty settings. i) Comparison of DaEPVsR fusolin with other homologues employs the deduced partial DaEPV sequence as presented in Figure 1, and the corresponding regions of other fusolin homologues. also as shown in Figure 1. Those regions of the latter proteins are identified in Table 2 (in brackets) by their amino acid residue numbers in their respective full length sequences. Comparisons used the GCG Gap algorithm as described above. 5 Bioassay of spindle body constituents against caterpillars Purified SBs of HaEPV and DaEPVsa were incorporated into artificial insect diet by addition and mixing when the preparation was at a temperature just above solidification point. Diet was then allowed to solidify, and was administered to neonate larvae ofHelicoverpa armigera and 10 Spodoptera litura. Larvae were individually housed, and were reared in darkness at a constant temperature of 28 0 C. Larval weights and developmental status were assessed periodically; resultant pupae were stored at 5"C prior to examination (see below).

WO 00/53000 PCT/AU00/00181 13 Care was taken to exclude any contribution of contaminant virus infection to outcomes of experiments. In the case of experiments using HaEPV, weights and development times of individual larvae were included in analyses only when (1) the individual larva successfully pupated and showed 5 a normal pupal morphology, and (2) the resultant pupa was judged not to be infected by virus, as assessed by examination of tissue by light microscopy. Thus, in these experiments every individual pupa was examined before inclusion of associated data into analyses. In the case of experiments using DaEPVSR, previous work has shown that neither caterpillar species used in 10 bioassays here is susceptible to infection with this beetle-derived pathogen. Nevertheless, as above, data were only included in analyses in cases where individual larvae successfully pupated and showed a normal pupal morphology; in these experiments however, only pupae from larvae exposed to the highest dosage of DaEPVSR spindle bodies in any given experiment 15 were assessed for the presence of virus. This methodology was designed to firstly ensure the validity of earlier studies, as noted above, and, secondly, to preclude the possibility of accidental contamination of larvae or experimental inoculum with viruses from other sources. No instance of DaEPVsla replication was observed. 20 Experiment A (#05-90526) The experiment aimed to determine whether consumption of EPV SBs and associated fusolin protein would result in reduced rates of growth of Helicoveipa armigera caterpillars. Accordingly, neonate larvae of H. arminigera were exposed to three dose rates of fusolin in SBs of HaEPV and 25 DaEPVsa (dosages of 5, 50 and 100 ptg fusolin/cc diet), and were assessed as described above. Seven days after commencement of the experiment, weights of subsequently "qualifying" larvae (see above) were as shown in Table 3 below: WO 00/53000 PCT/AU00/00181 14 Table 3: Weights of Helicoverpa armigera larvae after consumption of diet containing EPV spindle body constituents for seven days. treatment dose (pig/cc sample size mean wt (gin) standard error diet) control none 23 0.0714 0.0097 HaEPV 5 27 0.0521 0.0083 HaEPV 50 21 0.0543 0.0094 HaEPV 100 16 0.0233 0.0107 DaEPVSR 5 45 0.0642 0.0071 DaEPVSR 50 48 0.0525 0.0069 DaEPVsa 100 44 0.0591 0.0072 5 Examination of data by analysis of variance (ANOVA) showed no difference between mean weights of larvae in the control group and those fed preparations of DaEPVSR SBs (P = 0.2285), but showed that after seven days' exposure, larvae fed HaEPV SBs were significantly smaller than those in the 10 control group (P = 0.0201). Analysis of larval response to different dosages of HaEPV SBs failed (P = 0.0632) to show evidence of a significant relationship at a 5% confidence level. These data indicate that short term exposure of H. armigera larvae to the constituents of HaEPV SBs can lead to significant reductions in growth of 15 the animal. Experiment B (#07-90630) The experiment aimed to determine whether consumption of DaEPVsR SBs would affect growth of Helicoverpa armigera larvae if continued for a more lengthy period, or whether consumption for an initial seven day period 20 (as previously tested in Experiment A) would have an observable effect after a longer period of development. Accordingly, neonate larvae of Helicoverpa armigera were exposed to three dosages of DaEPVsa fusolin in SBs, and then assessed as described above. After seven days of feeding, larvae were weighed, and for each dosage regime, one sub-group was then allowed to feed 25 on normal diet ("7d exp/ 7d normal"), while the other continued to feed on a diet containing SBs ("14d exp"). After 7 days, no significant difference was observed between mean weights of control larvae and those exposed to WO 00/53000 PCT/AU00/00181 15 DaEPVSR SBs (P= 0.7791); this result is consistent with that reported from Experiment A above. After 14 days, all larvae were reweighed, with results as shown in Table 4 below. 5 Table 4: Weights of Helicoverpa armigera larvae after consumption of diet containing EPV spindle body constituents for seven days (with subsequent seven days feeding on regular diet), or continuously for 14 days. treatment fusolin dose sample size mean wt (gm) standard error (gg/cc diet) control none 9 0.4605 0.0389 7d exp/ 7d 5 16 0.4313 0.0348 normal 14d exp 5 11 0.2194 0.0176 7d exp/ 7d 50 17 0.4325 0.0337 normal 14d exp 50 10 0.2812 0.0185 7d exp/7d 100 15 0.3850 0.0359 normal 14d exp 100 9 0.2821 0.0195 10 Examination of data by analysis of variance (ANOVA) showed no difference between the mean weights of larvae in the control group and those fed preparations of DaEPVR SBs for 7 days prior to subsequent feeding for a further 7 days on normal diet (P = 0.3857). In contrast, highly significant differences were apparent between the mean weights of larvae in the control 15 group and those continuously fed preparations of DaEPVR SBs for 14 days (P = 0.0000), and between mean weights of the "7 day exposure/7 day normal diet" and "14 day continuous exposure" groups (P= 0.0000). This experiment thus indicates that short term exposure of H. armigera larvae to the constituents of DaEPVSR SBs has neither short-term nor longer 20 term consequences, but that continuous exposure for longer periods (e.g. 14 days) causes highly significant reduction in growth. Taken across all DaEPVSR dosages, mean caterpillar weight was 0.2588 gmin after 14 days exposure, as compared to a mean weight of 0.4605 gmin for unexposed animals, representing a reduction in growth of 44%.

WO 00/53000 PCT/AU00/00181 16 Experiment C (#14-91007) The purpose of this experiment was to determine whether consumption of either HaEPV or DaEPVsR SBs and associated fusolin protein would affect growth of Spodoptera litura caterpillars, either after a 7 day 5 period of exposure, a 7 day exposure followed by 5 days' access to normal diet, or continuous exposure for a 12 day period. Accordingly, neonate larvae of S. litura were exposed to one dose of SBs and associated fusolin of HaEPV (5 pg fusolin/cc diet), and to two dose rates of DaEPVSR SBs and associated fusolin (5 and 50 pg fusolin/cc diet). 10 After seven days of feeding larvae were weighed, and for each dosage regime, one sub-group was then allowed to feed on normal diet ("7d exp/5d normal"), while the other continued to feed on diet containing SBs ("12d exp"). After 7 days' feeding activity, no significant differences were observed between mean weights of control larvae and those exposed to various dosages 15 of SBs/fusolin. After a total of 12 days feeding, larvae were reweighed, with results as shown in Table 5 below. Table 5: Weights of Spodoptera litura larvae after consumption of diet containing EPV spindle body constituents for seven days (with subsequent 20 five days feeding on regular diet), or continuously for 12 days. treatment fusolin sample size mean wt (gm) standard error identity and dose ( g/cc diet) control none 25 0.7213 0.0464 7d exp/ 5d HaEPV; 5 14 0.7174 0.0557 normal 12d exp HaEPV; 5 11 0.1719 0.0629 7d exp/5d DaEPVSR; 5 21 0.6829 0.0509 normal 12d exp DaEPVsR; 5 17 0.1750 0.0566 7d exp/ 5d DaEPVsa; 50 16 0.5415 0.0509 normal 12d exp DaEPVSR; 50 15 0.1520 0.0526 WO 00/53000 PCT/AU00/00181 17 Examination of data by analysis of variance (ANOVA) showed no difference between the mean weights of larvae in the control group and those fed preparations of either HaEPV or DaEPVSR SBs for 7 days prior to subsequent feeding for a further 5 days on normal diet (P = 0.2973). In 5 contrast, highly significant differences were apparent between the mean weights of larvae in the control group and those continuously fed preparations of HaEPV SBs for 12 days (P = 0.0000), or DaEPVR SBs for 12 days (P = 0.0000). Likewise, highly significant differences were apparent between the mean weights of larvae in the group fed HaEPV SBs for seven 10 days only before feeding for 5 days on uncontaminated diet, and those continuously fed preparations of HaEPV SBs for 12 days (P = 0.0000). Similarly, weights for the same comparison at each dose rate of DaEPVR SBs were highly significant (P = 0.0000 for both dose rates). These data indicate that short term (i.e., up to 7 days) exposure of S. 15 litura larvae to the constituents of HaEPV and DaEPVSR SBs has neither short term nor longer-term consequences, but that continuous exposure for longer periods (e.g. 12 days) causes highly significant reduction in growth. Example 2: 20 Preparation of fusolin negative recombinant EPV In this example, the transfer vector pEPAS3 (Figure 3), which contains a bacterial lacZ gene inserted immediately upstream of the HaEPV fusolin coding sequence, in a manner that prevents expression of the latter, was used, together with wild-type HaEPV, to produce recombinant forms of 25 HaEPV in which fusolin production was replaced by production of the P galactosidase marker protein. Amplified stocks of that recombinant HaEPV were subsequently found to contain forms of the virus which produced neither the P-galactosidase marker nor the fusolin protein, as judged by the absence of SBs in preparations viewed by light microscopy. Two such 30 variants (pp5 and pp7) were isolated by repeated plaque purification and subsequent re-amplification in insect cell cultures. Harvested preparations of cells infected with these viruses were then fed to larvae of the moth Helicoverpa almigera, establishing, in turn, infections in those insects. Infected insects were processed to recover the products of these infections for 35 use in subsequent biological investigations, and preparations of virus stocks WO 00/53000 PCT/AU00/00181 18 known as pp7T6 and pp7S22 (or, following a second insect passage, pp7T6/5 and pp7S22/13) were ultimately selected for more detailed characterisation. Stocks of the wild-type clonal isolate wt#2/011293 (Osborne et al., 1996), which was used as the parental form for production of the original 3 5 galactosidase expressing recombinant, were carried in parallel through plaque purification, re-amplification, and feeding to recovery fromH. armigera insect hosts. Selected lines from these stocks (2C1 and 2D8, or 2C1/11 and 2D8/17) served as controls in the investigations described below. Light microscopy and scanning electron microscopy was used to 10 examine the composition and morphology of preparations of stocks pp7T6, pp7S22, 2G1 and 2D8. As expected, preparations of the wild-type viruses 2C1 and 2D8 were observed to contain both virus spheroids and SBs, while preparations of the recombinants pp7T6 and pp7S22 were observed to contain only spheroids. The spheroids of all four stocks appeared to be 15 morphologically identical. The molecular composition of preparations of these virus stocks was examined using the standard laboratory protocols of SDS-PAGE and Western blotting (see, for example, Sambrook et a]., 1989). As shown in Figure 4(a), Coomassie Blue staining of the separated protein constituents of all four 20 preparations showed a prominent band of about 115 kDa, corresponding to the major spheroid matrix protein (spheroidin; Hall & Moyer, 1991; Sriskantha et al., 1997), and numerous other less intense bands apparently common to each. Preparations of the two wild-type stocks also showed a band of protein with a mobility of about 50 kDa, (Figure 4[a], arrow) 25 corresponding to the monomeric form of the fusolin protein (Dall et al., 1993), that was not apparent in preparations of pp7T6 and pp7S22. A polyclonal antiserum to HaEPV fusolin protein (Dall et a]., 1993) and Western blotting protocols were then used to further characterise these virus stocks. As shown in Figure 4(b), both preparations of wild-type virus produced very 30 prominent immuno-reactive bands at a position corresponding to a molecular weight of about 50kDa (arrow), which, as expected, were not apparent in preparations of the two fusolin negative [fus

(

] recombinant forms. Feeding studies with fusolin negative recombinant EPV One wild-type isolate (2D8) and one recombinant (pp7T6) were then 35 selected for more detailed biological characterisation. Individually housed 48 hour old H. armigera larvae were exposed to a range of quantities of each WO 00/53000 PCT/AU00/00181 19 of the viruses by placing them on artificial diet spread with aliquots of virus dilution series. Seven days later ("post-infection"; 7 dpi) each larvae was weighed and at 21 dpi all larvae were collected, their developmental stage was recorded, and their status with respect to viral infection ( i.e. infected or 5 uninfected) was determined by examination of fat body smears by light microscopy. In all instances, larvae that died at or before 7 dpi were excluded from the assay, while those that were dead at 21 dpi were considered to be positive (i.e. infected). As shown in Figure 5, these experiments demonstrated that the wild 10 type virus isolate 2D8 was substantially more infectious than the fus recombinant pp7T6, with the former having an estimated IC 50 (this being the quantity of virus required to infect 50% of exposed larvae) of 0.2 spheroids/rnm 2 diet (sph/mm 2 ), while for pp7T6 it was 35 sph/mm 2 . Results of less detailed investigations with virus isolates 2C1 and pp7S22 were also 15 consistent with these results. Further analysis of the results has revealed, in addition, another fusolin associated phenomenon which has not previously been recognised, namely, that the presence of fusolin is associated with retardation of the rates of growth and development of exposed insect larvae, Thus, Figure 6 shows 20 mean weights of infected insects only, taken at 7 dpi, and calculated as a proportion of the weight of uninfected larvae from the same cohort (i.e. as a % of the weight of experimental controls). As can be observed, when the results were analysed in this manner it was clear that in the presence of fusolin, larval weight gain was much reduced. This analysis thus makes 25 allowance for the previously described observation (i.e. that the presence of fusolin enhances virus infectivity), and further shows that when intrinsic infectivity of a particular dose is used as the basis of comparison, this previously unrecognised effect of fusolin on insect growth can be observed. Similarly, and as shown in Figure 7, when the developmental fate of 30 those same infected insects, now pooled in three "categories" of infection rates, was assessed at 21 dpi, a much reduced proportion of larvae was observed to proceed to pupation in samples exposed to preparations of the wild type virus containing the fusolin protein.

WO 00/53000 PCT/AU00/00181 20 The above examples demonstrate the feasibility of strategies designed to effect oral ingestion of constituent SB/SLB protein(s) such as fusolin by feeding insects as a means of inhibiting feeding, growth and/or development 5 of such insects. Such strategies may therefore be of significant value with respect to limiting losses to commodity materials that result from insect feeding activity. That is, it can be appreciated that small insects cause less feeding damage to plants than do larger ones, and that retarding the growth and/or development of insects will increase the time-span during which 10 factors such as adverse environmental conditions, predators, and/or artificially applied chemical and biological agents may effect their control. In addition, it is widely recognised that early instar (i.e., smaller) insects are intrinsically more susceptible to infection with, or the activity of, a variety of chemical and biological control agents such as the bacterium Bacillus 15 thuringiensis ("Bt"). It will be appreciated by persons skilled in the art that numerous variations and/or modifications may be made to the invention as shown in the specific embodiments without departing from the spirit or scope of the invention as broadly described. The present embodiments are, therefore, to 20 be considered in all respects as illustrative and not restrictive.

WO 00/53000 PCT/AU00/00181 21 References: Adams JR., McClintock JT. Baculoviridae. Nuclear polyhedrosis viruses. Part 1. Nuclear polyhedrosis viruses of insects. In JR Adams, J.R. Bonami, editors: 5 Atlas of Invertebrate Viruses, Boca Raton: CRC Press, 1991. p 87-204. Adams JR, Wilcox TA.. Histopathology of the almond moth, Cadra cautella, infected with a nuclear-polyhedrosis virus. J Invertebr Pathol 1968;12:269 274. 10 Ahrens CIH, Russell RL, Funk CJ, Evans JT, Harwood SH, Rohrmann GF. The sequence of the Orgyia pseudotsugata multinucleocapsid nuclear polyhedrosis virus genome. Virology 1997;229: 381-399. 15 Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J. Mol. Biol. 1990;215:403-410. Arif BM. Recent advances in the molecular biology of entomopoxviruses. J Gen Virol 1995;76:1-13. 20 Ayres MD, Howard SC, Kuzio J, Lopez-Ferber M, Possee RD. The complete DNA sequence of Autographa californica nuclear polyhedrosis virus. Virology 1994;202:586-605. 25 Cunningham JC. An ultrastructural study of the development of a nuclear polyhedrosis virus of the eastern hemlock looper, Lambdina fiscellaria fiscellaria. Can J Microbiol 1971;17:69-72. Dall DJ, Sriskantha A, Vera AP, Lai-Fook J, Symonds TM. A gene encoding a 30 highly expressed spindle body protein of Heliothis armigera entomopoxvirus. J Gen Virol 1993;74:1811-1818. Devereux J. Heaberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nuc Acids Res 1984;12:387-395. 35 WO 00/53000 PCT/AU00/00181 22 Fernon CA, Vera AP, Crnov R, Lai-Fook J, Osborne RJ, Dall DJ. In vitro replication of Heliothis armigera EPV. J Invertebr Pathol 1995;66:216-223. Gomi S, Majima K, Maeda S. Sequence analysis of the genome of Bombyx 5 mori nucleopolyhedrovirus. J Gen Virol 1999;80:1323-1337. Goodwin RH, Milner RJ, Beaton CD. Entomopoxvirinae. In JR Adams, J.R. Bonami, editors: Atlas of Invertebrate Viruses, Boca Raton: CRC Press, 1991. p 393-434. 10 Gross CH, Wolgamot GM, Russell RLQ, Pearson MN, Rohrmann GF. A 37 kilodalton glycoprotein from a baculovirus of Orgyia pseudotsugata is localized to cytoplasmic inclusion bodies. J Virol 1993;67:469-475. 15 Hall RL, Moyer RW. Identification, cloning, and sequencing of a fragment of Amsacta minoorei entomopoxvirus DNA containing the spheroidin gene and three vaccinia virus-related open reading frames. J Virol 1991;65:6516-6527. Hayakawa T, Xu J, Hukahara, T. Cloning and sequencing of the gene for an 20 enhancing factor from Pseudaletia separata entomopoxvirus. Gene 1996;177:269-270. Hayakawa T, Ko R, Okano K, Seong SI, Goto C, Maeda S. Sequence analysis of the Xestia c-nigrumn granulovirus genome. Virology 1999;262:277-297. 25 Huger AM, Krieg A. On spindle-shaped cytoplasmic inclusions associated with a nuclear polyhedrosis of Choristoneura murinana. J Invertebr Pathol 1968;12:461-462. 30 Hukuhara T, Hayakawa T, Wijonarko A. Increased baculovirus susceptibility of armnyworm larvae feeding on transgenic rice plants expressing an entomopoxvirus gene. Nature Biotechnology 1999;17:1122-1124. Kuzio J, Pearson MN, Harwood SH, Funk CJ, Evans JT, Slavicek JM, 35 Rohrmann GF. Sequence and analysis of the genome of a baculovirus pathogenic for Lymantria dispar. Virology 1999;253:17-34.

WO 00/53000 PCT/AU00/00181 23 Lai-Fook J, Dall DJ. Spindle bodies of Heliothis armigera entomopoxvirus develop in structures associated with host cell endoplasmic reticulum. J Invertebr Pathol (in press). 5 Liu JJ, Carstens EB. Identification, molecular cloning, and transcription analysis of the Choristoneurafumiferana nuclear polyhedrosis virus spindle like protein gene. Virology 1996;223: 396-400. 10 Mitsuhashi W, Furuta Y, Sato M. The spindles of an entomopoxvirus of Coleoptera (Anomala cuprea) strongly enhance the infectivity of a nucleopolyhedrovirus in Lepidopteria (Bombyx mori). J. Invertebr. Pathol. 1998;71:186-188. 15 Moss, B. Poxviridae: the viruses and their replication. In BN Fields, DM Knipe and PM Howley, editors: Fields Virology. Philadelphia, Lippincott Raven Publishers, 1996. p 2637-2671. Murphy, F.A., Fauquet, C.M., Bishop, D.H.L., Ghabrial, S.A., Jarvis, A.W., 20 Martelli, G.P., Mayo, M.A., and Summers, M.D. (editors) Virus Taxonomy. Sixth Report of the International Committee on Taxonomy of Viruses. Vienna & New York: Springer-Verlag, 1995. Osborne RJ, Symonds TM, Sriskantha A, Lai-Fook J, Fernon CA, Dall DJ. An 25 entomopoxvirus homologue of the vaccinia virus D13L-encoded "rifampicin resistance" protein. J Gen Virol 1996;77:839-846. Phanis CG, Miller DP, Cassar SC, Tristem M, Thiem SM, O'Reilly DR. Identification and expression of two baculovirus gp37 genes. J Gen Virol 30 1999;80:1823-1831. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory.

WO 00/53000 PCT/AU00/00181 24 Smirnoff WA. Rhombohedral twisted crystalloids found in the cytoplasm of nuclear polyhedrosis infected larvae of the ugly-nest caterpillar. Can J Microbiol 1970;16:906-907. 5 Sriskantha A, Osborne RJ, Dall DJ. Mapping of the Heliothis armigera entomopoxvirus (HaEPV) genome, and analysis of genes encoding the HaEPV spheroidin and nucleoside triphosphate phosphohydrolase I proteins. J Gen Virol 1997;78:3115-3123. 10 Xu J, Hukuhara T. Enhanced infection of a nuclear polyhedrosis virus in larvae of the arminyworm, Pseudaletia separata, by a factor in the spheroids of an entomopoxvirus. J Invertebr Pathol 1992;60:259-264. Xu J, Hukuhara T. Biochemical properties of an enhancing factor of an 15 entomopoxvirus. J Invertebr Pathol 1994;63:14-18.

Claims (22)

1. A plant transformed with at least one polynucleotide molecule comprising a nucleotide sequence(s) encoding one or more constituent 5 protein(s) of spindle bodies (SBs) or spindle-like bodies (SLBs) from an insect virus, said nucleotide sequence(s) being operably linked to a suitable promoter sequence(s), wherein said transformed plant expresses said protein(s) in, at least, plant tissue or tissues susceptible to damage by feeding insects. 10

2. A plant according to claim 1, wherein the one or more constituent protein(s) is/are selected from fusolins, fusolin-like proteins and ER-specific chaperone BiP proteins. 15

3. A plant according to claim 1 or 2 which expresses a fusolin protein.

4. A plant according to claim 3, wherein the fusolin protein is selected from fusolins from Heliothis armigera EPV (HaEPV), Pseudaletia separata EPV (PsEPV), Choristoneura biennis EPV (CbEPV) and Dermolepida albohlirtum 20 EPV.

5. A plant according to claim 1 or 2 which expresses a fusolin-like protein. 25

6. A plant according to claim 5, wherein the fusolin-like protein is selected from fusolin-like proteins fromAutographa californica (AcMNPV), Bombyx mori (BmnMNPV), Choristoneura fumiferana (CfMNPV), Lymcuantria dispar (LdMNPV), Orgyia pseudotsugata NPVs (OpMNPV) and Xestia c nigrum GV (XcGV). 30

7. A plant according to any one of the preceding claims which further expresses an exogenous toxin or other agent that is deleterious to insects.

8. A plant according to claim 7, wherein the exogenous toxin is selected 35 from Bacillus thuringiensis 5-toxin and insect neurohormones. WO 00/53000 PCT/AU00/00181 26

9. A feed bait composition comprising spindle bodies (SBs) or spindle like bodies (SLBs) from an insect virus, or one or more constituent protein(s) of said spindle bodies or spindle-like bodies, together with an agriculturally acceptable carrier. 5

10. A feed bait composition according to claim 9, wherein the one or more constituent protein(s) is/are selected from fusolins, fusolin-like proteins and ER-specific chaperone BiP proteins. 10

11 A feed bait composition according to claim 9 or 10, wherein the one or more constituent protein(s) is a fusolin protein.

12. A feed bait composition according to claim 11, wherein the fusolin protein is selected from fusolins from Heliothis armigera EPV (HaEPV), 15 Pseudaletia separata EPV (PsEPV), Choristoneura biennis EPV (CbEPV) and Dermolepida albohirtun EPV.

13. A feed bait composition according to claim 9 or 10, wherein the one or more constituent protein(s) is a fusolin-like protein. 20

14. A feed bait composition according to claim 13, wherein the fusolin-like protein is selected from fusolin-like proteins fromAutographa californica (AcMNPV), Bominbyx mori (BmMNPV), Choristoneura fiumiferana (CfMNPV), Lymanltria dispar (LdMNPV), Orgyia pseudotsugata NPVs (OpMNPV) and 25 Xestia c-nigrum GV (XcGV).

15. A feed bait composition according to any one of claims 9-14, wherein the spindle bodies, spindle-like bodies or constituent protein(s) comprise 0.05 to 15.0% (by weight) of the composition. 30

16. A feed bait composition according to any one of claims 9-15, further comprising a pheromone(s) or other chemical attractive to insects.

17. A feed bait composition according to any one of claims 9-16, wherein 35 the agriculturally acceptable carrier is selected from edible substances. WO 00/53000 PCT/AU00/00181 27

18. A method of controlling or preventing damage caused to plants from feeding insects, said method comprising applying to said plant a feed bait composition according to any one of claims 9-17 before, after or together with an insecticidal chemical and/or biological agent. 5

19. A method of controlling or preventing damage caused to a plant according to any one of claims 1-8 from feeding insects, said method comprising applying to said plant an insecticidal chemical and/or biological agent. 10

20. A method according to claim 18 or 19, wherein the insecticidal chemical is selected from organophosphate compounds.

21. A method according to claim 18 or 19, wherein the biological agent is 15 selected from pathogenic bacteria.

22. A method according to claim 18 or 19, wherein the biological agent is selected from insect viruses.